Stem Cell Market Research Reports & Industry Analysis
Stem cells are undifferentiated cells of most multi-cellular living organisms able to renew themselves and to repair or create new cells of whatever body’s tissue. They are classified into the two principal categories: adult/“somatic” and embryonic stem cells. According to stem cells’ “potency” the following types are distinguished: totipotent, oligopotent, pluripotent, unipotent, multipotent and stem cells. Oncology, bone/cartilage and cardiology therapeutic industries are the main users of stem cells.
In 2010, the world stem cell market exceeded USD 21 billion. It exhibited considerable upturn over the recent several years and is expected to override USD 63 billion in 2015. North America, Europe and the Asia-Pacific are the top regional markets. The market growth is spurred by the rising demand given the enhancing consumers’ interest in the stem cell products. Geron, Advanced Cell Technology and Neuralstem are the dominant players of the worldwide market.
This MarketPublishers’ catalogue contains research reports providing an extensive guide to the stem cell market. The studies include valuable information on the market size and structure; characterize the market dynamics; identify major factors influencing the market. The researches examine the competitive landscape; describe performance of the leading companies, besides offering their detailed profiles. In addition, data on price trends, consumption changes, the most recent industry activities, product launches as well as future market forecasts are available in the research reports.
... the maladies associated with aging (dementia, Alzheimer's etc.) are on the rise!. Consequently the pharma industry continues to grow and is projected to achieve ... diseases are treated is the Stem cell therapy/Regenerative Medicine space. The number of companies and products in the clinic have reached a critical ...Jan, 2015 98 pages
... blood bank is the fastest-growing and relatively mature market amid stem cell upstream sectors and even the whole industry chain. In ... industry; Policies, upstream/midstream/downstream development, etc. of China stem cell industry; Operation, stem cell business, etc. of 6 upstream companies and 19 midstream/ ...Sep, 2014 107 pages
... for the treatment of acute graft-versus-host disease (GVHD) in children. This allogeneic therapy was approved in New Zealand and Canada, in May 2012. Additionally, allogeneic stem cell therapy market is expected to grow at a higher CAGR as compared to the autologous stem cell therapy. ...Apr, 2014 196 pages
Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells. Global stem cell market ... transplant Transplant Medicine Regenerative Medicine Others Cord Blood Banking Blood Transfusion Cell Based Genetics Global Stem cell UCB market by Geography UCB market ...Jan, 2014 148 pages
This report analyzes the worldwide markets for Mesenchymal Stem Cells in US$ Million. The report provides separate comprehensive analytics for the US, ... including many key and niche players such as - Aastrom Biosciences, Inc. Cell Applications, Inc. Celprogen, Inc. Cyagen Biosciences Inc. EMD Millipore ...Jan, 2014 179 pages
... 350 Million at preservation level of 1% which can increase to more than US$ 1 Billion at stem cell preservation level of 3% for new born babies. Many factors have ... of international companies are operating in the stem cell banking market of India. “India Cord Blood Stem Cell Banking Market” research report ...Feb, 2014 58 pages
Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells. Global stem cell ... transplant Transplant Medicine Regenerative Medicine Others Cord Blood Banking Blood Transfusion Cell Based Genetics Global Stem cell UCB market by Geography UCB market in ...Jan, 2014 148 pages
... Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, ... parameters for each drug profile in development phase are covered in “Global Cell Therapy Pipeline Analysis” research report: Drug Profile Overview ...Sep, 2013 220 pages
... classified as either embryonic, adult (tissue-specific or cord blood) stem cells. Recent understanding of stem cell biology may provide new approaches for ... Publications report is to describe the specific market segments of the medical research space using stem cells for research and development (R&D) purposes ...Aug, 2013 306 pages
... analyzes the umbilical cord blood marketplace from a technical as well as market perspective describing the types of transplantation utilizing cord blood, disease ... into stem cell research trends (both qualitative and quantitative). This data-driven characterization of the adult stem cells market landscape ...Jan, 2011 100 pages
... are well considered and complicate is ensured for maintaining quality parameters. India is poised to emerge as the largest source for umbilical cord blood ... of international companies are operating in the stem cell banking market of India. “India Stem Cell Banking Market Analysis” research report outlines ...Apr, 2013 55 pages
... Direct’s, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014’, provides an overview of the Hematopoietic Stem Cell Transplantation’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hematopoietic Stem Cell Transplantation, complete with ...Apr, 2014 115 pages
... provides comprehensive understanding and unprecedented access to the Regenerative medicine and Stem cells partnering deals and agreements entered into by the worlds ... and stem cells partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license ...Aug, 2013 787 pages
... , etc. have high penetration rates of stem cell banking ranging from 15% to 30%. Regions such as, US, Europe, China and India have low penetration rates of ... cells from embryos. The report titled ‘Indian Stem Cell Banking Market: Trend and Opportunities (2012-2017)’ provides an in-depth analysis of the Indian ..Dec, 2012 54 pages
... rapid improvements in efficacy of treatment; it has enormous advantages over allogenic stem cell therapies. Autologous transplants are relatively safe procedures, with less ... Cell Therapy (2012-2017)” provides details about various ACT based treatments and their application areas. Every health regulatory bodies ...Oct, 2012 130 pages
... Direct’s, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014’, provides an overview of the Hematopoietic Stem Cell Transplantation’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hematopoietic Stem Cell Transplantation, complete with ...Oct, 2014 102 pages
This report analyzes the worldwide markets for Human Embryonic Stem Cell (hESC) Research in US$ Million. The report provides separate comprehensive ... key and niche players such as Advanced Cell Technology, Inc., BD Biosciences, BioTime, Inc., Cell Cure Neurosciences Ltd., Cellartis AB, GE Healthcare, Millipore ...Jul, 2012 299 pages
... the market size and growth prospect of the stem cell banking market in India. In addition to these, the report gives a snapshot of the ... the industry that include favourable regulatory environment, high patient population, stem cell application in drug development, rising consumer awareness, a rise in medical ...Jul, 2012 65 pages
... business intelligence provider, has released its latest research, “Translational Regenerative Medicine%-%Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative ... cell research, gene therapy and tissue engineering. The report also includes insights into the late-stage R&D pipeline for regenerative ...Jun, 2012 95 pages
... new technologies that increase the possibility to launch new therapies in the market place. At present, there has been a spur in investments from pharmaceutical ... companies have planned and aligned their objectives to enter the stem cell market in the next 3-5 years, with a few strategic partnerships already ...Nov, 2011 160 pages
... cord injury, blindness, immune system disorders and cardiovascular disease. Stem Cells - The Hype and the Hope 2010-2025 provides an analytical ... benefits in particular: You will receive a comprehensive analysis of the prospects for stem cells from 2010 to 2025, including predicted revenues, growth rates ...May, 2010 201 pages
... cell transplantation (HSCT) Uses for umbilical cord blood and related technologies Supply, storage (banking) and processing of the cellular material. That ... activities, results, R&D, and outlooks for future success. Stem Cell Technologies: World Market Outlook 2013-2023 gives independent analysis. There ...Aug, 2013 151 pages
... themselves through mitotic cell division and can differentiate into a wide range of specialized cell types. As stem cells can be readily grown ... is particularly controversial because, with the present state of technology, starting a stem cell line requires the destruction of a human embryo and/or therapeutic ...Jan, 2012 155 pages
GLOBAL MARKET WATCH:
Global stem cells market is forecasts to reach US$63.8 billion by 2015 from an estimated value of US$21.5 billion in 2010, exhibiting a triple fold growth rate during the period 2010-2015. The...
This report analyzes the US Market for Stem Cells Research in US$ Million. Annual forecasts are provided for the period 2006 through 2015. The ... , Inc., Osiris Therapeutics, StemCells, Inc., ThermoGenesis Corp., and ViaCord, LLC. Market data and analytics are derived from primary and secondary research. ...Feb, 2011 566 pages
... leading business intelligence provider, has released its latest research “Targeted Therapeutics - Advancement in Gene Therapy and Stem Cell Therapy will Drive ... is detailed for understanding the approval procedure of TT with main focus on gene and stem cell therapy. Major companies dealing in TT are profiled ...Feb, 2011 100 pages
Embryonic stem cell (hESC) research has attracted a lot of attention the world over and the controversy surrounding it just does not seem to die down. Stem cells are unspecialized cells that are capable of differentiating into any other cell type....Jul, 2010 216 pages
The ‘Stem Cells Market and Applications: (2009-2015)’ reviews the latest Stem Cells market trends with a perceptive to disclose the near-future growth prospects. An in-depth analysis across the geographic regions provides...Jul, 2010 468 pages
The ‘Stem Cells Market and Technologies, 2009-2015’ reviews the latest trends in the stem cells market with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic...Jul, 2010 472 pages
Advancements in science and technology have enabled in increasing the number of preserved cord blood units being used in regenerative medicine applications. Expectant parents can decide to store their...
... cost of the therapy may affect market growth. The global stem cell market is estimated to be $88.3 billion by 2014, growing at a CAGR of 14.8 % from 2009 ... MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts ...Nov, 2009 229 pages